Publication | Open Access
Immunotherapy beyond progression in patients with advanced non-small cell lung cancer
36
Citations
26
References
2020
Year
IBP is associated with longer OS and PFS in patients with aNSCLC. Our findings may suggest new therapeutic options for patients with aNSCLC who experienced disease progression after initial immunotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1